Pfizer Stock Stock News Today

PFE -  USA Stock  

USD 51.34  0.67  1.32%

Pfizer Stock News module provides quick insight into current market opportunities from investing in Pfizer Inc. Use historical and current headlines to determine the investment entry and exit points. Many technical investors use Pfizer Inc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Please check Pfizer Hype Analysis, Pfizer Correlation and Pfizer Performance.
  
Refresh
Pfizer stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Pfizer daily returns and investor perception about the current pice of Pfizer Inc as well as its diversification or hedging effects on your existing portfolios.
a day ago at www.fool.com         
Pfizers Setbacks With Paxlovid Are Mounting -- Should Investors Be Concerned - The Motley Fool
fool News
3 days ago at simplywall.st         
This Insider Has Just Sold Shares In Pfizer Inc. - Simply Wall St
Simply Wall St News at Macroaxis
few days ago at www.macroaxis.com         
Pfizer exotic insider transaction detected
Macroaxis News
few days ago at www.macroaxis.com         
Discretionary transaction by Mikael Dolsten of 15167 shares of Pfizer subject to Rule 16b-3
Macroaxis News
six days ago at www.tipranks.com         
Pfizer Biohaven Combine Forces Vying for Valuable Upside - TipRanks
news
over a week ago at www.benzinga.com         
Mid-Day Market Update U.S. Stocks Turn Lower Biohaven Pharmaceutical Shares Jump - Benzinga - Benzin...
benzinga news
over a week ago at www.business2community.com         
Pfizer exotic insider transaction detected
news
over a week ago at www.marketwatch.com         
Amgen Inc. stock rises Wednesday, still underperforms market - MarketWatch
marketwatch News
over two weeks ago at www.cnbc.com         
Pfizer cuts 2022 earnings outlook despite strong first-quarter Covid vaccine and antiviral sales - C...
cnbc News
over two weeks ago at www.nasdaq.com         
Acquisition by Jennifer Damico of tradable shares of Pfizer subject to Rule 16b-3
nasdaq News
over two weeks ago at 247wallst.com         
Acquisition by Dan Littman of 4059 shares of Pfizer subject to Rule 16b-3
news
over two weeks ago at www.schaeffersresearch.com         
Why Pfizer Stock Is Anything But a Safe Bet for Investors - Schaeffers Research
news
over two weeks ago at www.schaeffersresearch.com         
The 5 Best Healthcare Stocks To Own Right Now - Schaeffers Research
news
over two weeks ago at www.fool.com         
Did Johnson Johnsons CFO Just Spell Trouble for Moderna and Pfizer - The Motley Fool
fool News
over three weeks ago at www.fool.com         
Could Pfizer Stock Help You Become a Millionaire - The Motley Fool
fool News
There is far too much social signal, news, headlines, and media speculation about Pfizer that is available to investors today. That information is available publicly through Pfizer media outlets and privately through word of mouth or via Pfizer internal channels. However, regardless of the origin, that massive amount of Pfizer data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Pfizer news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pfizer relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pfizer's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pfizer alpha.

Pfizer Performance against DOW

 Price Growth (%)  
      Timeline 
1
Exercise or conversion by Sally Susman of 63580 shares of Pf...02/23/2022
2
Acquisition by Albert Bourla of 362427 shares of Pfizer subj...02/25/2022
3
Payment of 1795 shares by William Carapezzi of Pfizer subjec...02/28/2022
4
Exercise or conversion by Mcdermott Michael of 12340 shares ...03/01/2022
5
Exercise or conversion by Mikael Dolsten of 158331 shares of...03/04/2022
6
Arena Pharma ticks higher on Nasdaq delisting notice for Pfi...03/08/2022
7
Acquisition by Jennifer Damico of 329 shares of Pfizer subje...03/17/2022
8
EPS Estimate03/31/2022
9
Acquisition by Pao William of 115897 shares of Pfizer subjec...04/01/2022
10
Acquisition by Joseph Echevarria of 836 shares of Pfizer sub...04/04/2022
11
Pfizer to Acquire ReViral and Its Respiratory Syncytial Viru...04/07/2022
12
Veru Stock Soars, Retreats After Impressive Data From Covid ...04/12/2022
13
Acquisition by Jennifer Damico of 260 shares of Pfizer subje...04/14/2022
14
Pfizer Upgraded to Strong-Buy at StockNews.com - MarketBeat04/18/2022
15
Pfizer A Portfolio Prescription For Inflation Investing - Se...04/21/2022
16
The 5 Best Healthcare Stocks To Own Right Now - Schaeffers R...04/27/2022
17
Acquisition by Jennifer Damico of tradable shares of Pfizer ...05/02/2022
18
EPS Reported05/03/2022
19
Pfizer exotic insider transaction detected05/09/2022
20
Discretionary transaction by Mikael Dolsten of 15167 shares ...05/12/2022
21
EPS Estimate05/13/2022
22
Pfizers Setbacks With Paxlovid Are Mounting -- Should Invest...05/17/2022
Please check Pfizer Hype Analysis, Pfizer Correlation and Pfizer Performance. Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for Pfizer Stock analysis

When running Pfizer Inc price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Is Pfizer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine Pfizer value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.